Today at the Drug Discovery Chemistry conference in San Diego, Emily, Associate Director, Medicinal Chemistry, presents on our proprietary platform to develop RNA-targeted small molecule (rSMs) medicines.
#ArrakeensInAction
Today we recognize International Transgender Day of Visibility, and we celebrate the lives and contributions of trans people.
In keeping with our core value of Being Human, we also draw attention to the challenges the community faces. #TDOV2026
glaad.org/tdov/
Since Pi Day fell on Saturday this year (3/14), Arrakeens celebrated early! We provided the pizza “pie" and team members brought in their favorite pies for dessert (so many flavors!) to help us contemplate the value of pi.
#PiDay #PiDay2026 #ArrakeensInAction
Today at the Muscular Dystrophy Association Clinical & Scientific Conference, Domi Stickens, PhD, CSO, presents a poster highlighting our RNA-targeted small-molecule therapeutics and first oral therapy in development for myotonic dystrophy type 1 (DM1).
#MDAconference #ArrakeensInAction
Yesterday was #InternationalWomensDay, and we recognize all of the women in our lives, especially celebrating the women of Arrakis — the scientists, leaders and innovators advancing RNA-targeted small molecule medicines and shaping the future of drug discovery.
#WomenInSTEM #IWD2026
Tomorrow is #RareDiseaseDay, and we stand with all people affected by myotonic dystrophy type 1 (DM1) — a rare, inherited disease that impacts many parts of the body and daily life. We’re developing the first oral therapy in development for DM1.
#RareDiseaseDay2026 #DM1 #MyotonicDystrophy
Arrakeens came together to celebrate #LunarNewYear2026 with a festive lunch from local favorite Mu Lan Taiwanese Restaurant. This gave us the opportunity to pause, connect, and celebrate the diverse cultures and traditions that strengthen Arrakis and our community.
#YearOfTheHorse #WeAreArrakeen
Today we celebrate #LunarNewYear2026 and welcome the Year of the Horse, which brings energy, adventure, and momentum. Arrakeens are ready to embrace all of these! #YearOfTheHorse
On International Day of Women & Girls in Science, we recognize and celebrate the talented scientists at Arrakis and around the world working to create new medicines and make a difference for patients. #February11 #WomenInScience #WomenScienceDay
Learn more: www.womeninscienceday.org
February is #BlackHistoryMonth, and we honor the achievements, resilience, and lasting contributions of Black scientists, innovators, and leaders whose work has shaped medicine and advanced human health.
We believe diverse perspectives strengthen science and drive better outcomes for patients.
This Martin Luther King Jr. Day, we celebrate the life and enduring legacy of a remarkable American leader. His courage and leadership in the Civil Rights Movement helped shape our nation. His powerful reminder: “Injustice anywhere is a threat to justice everywhere.”
#DrMartinLutherKingJr #MLKDay
Our CEO Michael Gilman and CBO James Mutamba will be in San Francisco for the JPM conference next week, Jan 12-15. Looking forward to great meetings and connections, and we hope to see you there!
#ExpeditionRNA #JPM2026
We’re welcoming 2026 with renewed focus. Our team remains committed to advancing RNA-targeted medicines and continuing the important work ahead. Wishing all a bright, healthy start to the new year!
#ExpeditionRNA
It’s the holiday season, and Arrakeens are ready to relax, refresh, and spend time with their loved ones. Our office will be closed until 2026.
Wishing all #HappyHolidays and a Happy New Year.
Our team gathered for a casual holiday get-together, sharing food, laughter, and a chance to appreciate the incredible people behind our mission. Our gingerbread house creations were truly inspired and festive! Grateful for this team today and every day.
#ExpeditionRNA
Our CEO Michael Gilman and CBO James Mutamba will be in San Francisco for the JPM conference next month, Jan 12-15, 2026. Looking forward to great meetings and connections!
#ExpeditionRNA #JPM2026
Our Founder & CSO Emerita Jennifer Petter is the scientific keynote speaker today at the 2025 Advancing Drug Development Forum, discussing our mission to create RNA-targeted small molecules (rSM) and how they are opening an entirely new therapeutic space.
#ADDF2025 #PharmaInnovation #DrugDiscovery
Today at the RNA Targeted Drug Discovery Summit, CSO Domi Stickens PhD will present on our lead oral RNA-targeted small molecule (rSM) drug program for myotonic dystrophy type 1 (DM1). We plan to advance this rSM to an IND filing in 2026.
arrakistx.com/press-releas...
#ArrakeensInAction #BioSky
This week we’ll be at the RNA Targeted Drug Discovery Summit in Boston. CSO Domi Stickens will present on our RNA-targeted small molecule (rSM) drug program for myotonic dystrophy type 1 (DM1), and Founder & CSO Emerita Jennifer Petter shares her expertise on two panels.
#ArrakeensInAction #BioSky
This week we slow down and express gratitude for our phenomenal team and their commitment to each other, our core values, and our mission.
Happy Thanksgiving to all.
#ExpeditionRNA
We’re proud to support the trans community as we recognize Transgender Awareness Week. Aligned with our core value of Being Human, we’re helping raise awareness and increase understanding about transgender people and the challenges they face. #TransAwarenessWeek
glaad.org/transweek/
Today, we join the world in recognizing UNESCO World #ScienceDay. This year’s theme: ‘Trust, Transformation, and Tomorrow: The Science We Need for 2050’ makes us excited about our mission to change the way challenging diseases are treated. #ExpeditionRNA
Learn more: www.unesco.org/en/days/scie...
We recognize #InternationalPronounsDay today, in keeping with our core value of Being Human. We affirm the respect and human dignity of referring to people by their chosen pronouns.
Learn more: pronouns.org
#DareToBeArrakeen
Today we honor Indigenous Peoples’ Day, recognizing and celebrating Indigenous American peoples and commemorating their histories and cultures. We acknowledge those that originally called this land their home. #IndigenousPeoplesDay
It’s #NationalHispanicHeritageMonth Sept 15-Oct 15, and we’re proud to celebrate the culture and achievements of the Hispanic and Latino communities.
Learn more:
hispanicheritagemonth.gov/index.html
Last week, we wore green for International #myotonicDystrophyAwareness Day (9/15) to raise awareness of the most common form of adult muscular dystrophy. We're developing an RNA-targeted small molecule drug program to treat myotonic dystrophy type 1 (DM1).
#myotonicDystrophy
The Arrakis team gathered to volunteer at Waltham Fields Community Farm, helping with weeding and preparing their fall harvests. We’re glad to support the Farm, its educational programs, and the food it produces for the Waltham community.
#ArrakeensInAction
At the Discovery on Target: RNA and DNA Targeting Small Molecule Drugs conference in Boston today, Emily, Associate Director, Medicinal Chemistry, presents on our proprietary platform to develop RNA-targeted small molecule (rSMs) medicines.
#ArrakeensInAction
Monday at the HBM Biopharma Summit 2025 in Zurich, our Chief Business Officer James Mutamba will give a corporate presentation and Arrakis overview.
#ExpeditionRNA
Our CEO Michael Gilman will share his experiences and discuss what it takes to scale innovation for lasting impact during a fireside chat today at the BioPort Atlantic 2025 conference in Halifax.
#ExpeditionRNA
